{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:17:07Z","timestamp":1786979827185,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T00:00:00Z","timestamp":1498694400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Godfrey S. Pettit Respirology Block Term Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00228-017-2278-3","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T23:38:25Z","timestamp":1498693105000},"page":"1287-1295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Adverse cardiac events associated with incident opioid drug use among older adults with COPD"],"prefix":"10.1007","volume":"73","author":[{"given":"Nicholas T.","family":"Vozoris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis E.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Rochon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,29]]},"reference":[{"key":"2278_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/bcp.12762","volume":"81","author":"NT Vozoris","year":"2016","unstructured":"Vozoris NT, Wang X, Fischer HD, Gershon AS, Bell CM, Gill SS et al (2016) Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Br J Clin Pharmacol 81:161\u2013170","journal-title":"Br J Clin Pharmacol"},{"key":"2278_CR2","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.2147\/COPD.S112484","volume":"11","author":"Z Ahmadi","year":"2016","unstructured":"Ahmadi Z, Bernelid E, Currow DC, Ekstrom M (2016) Prescription of opioids for breathlessness in end-stage COPD: a national population-based study. Int J Chron Obstruct Pulmon Dis 11:2651\u20132657","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2278_CR3","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1378\/chest.128.4.2640","volume":"128","author":"L Huiart","year":"2005","unstructured":"Huiart L, Ernst P, Suissa S (2005) Cardiovascular morbidity and mortality in COPD. Chest 128:2640\u20132646","journal-title":"Chest"},{"key":"2278_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.annepidem.2005.04.008","volume":"16","author":"SM Curkendall","year":"2006","unstructured":"Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr et al (2006) Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada. Ann Epidemiol 16:63\u201370","journal-title":"Ann Epidemiol"},{"key":"2278_CR5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","volume":"356","author":"PM Calverley","year":"2007","unstructured":"Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, TORCH investigators et al (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775\u2013789","journal-title":"N Engl J Med"},{"key":"2278_CR6","first-page":"H2157","volume":"268","author":"JE Schultz","year":"1995","unstructured":"Schultz JE, Rose E, Yao Z, Gross GJ (1995) Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Phys 268:H2157\u2013H2161","journal-title":"Am J Phys"},{"key":"2278_CR7","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1006\/jmcc.1996.0182","volume":"28","author":"GL Chien","year":"1996","unstructured":"Chien GL, Van Winkle DM (1996) Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J Mol Cell Cardiol 28:1895\u20131900","journal-title":"J Mol Cell Cardiol"},{"key":"2278_CR8","doi-asserted-by":"crossref","first-page":"H1786","DOI":"10.1152\/ajpheart.01143.2003","volume":"287","author":"S Okubo","year":"2004","unstructured":"Okubo S, Tanabe Y, Takeda K, Kitayama M, Kanemitsu S, Kukreja RC et al (2004) Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor. Am J Physiol Heart Circ Physiol 287:H1786\u2013H1791","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2278_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00075198-200202000-00005","volume":"8","author":"MR Pinsky","year":"2002","unstructured":"Pinsky MR (2002) Recent advances in the clinical application of heart-lung interactions. Curr Opin Crit Care 8:26\u201331","journal-title":"Curr Opin Crit Care"},{"key":"2278_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00000542-198206000-00001","volume":"56","author":"H Sonntag","year":"1982","unstructured":"Sonntag H, Larsen R, Hilfiker O, Kettler D, Brockschnieder B (1982) Myocardial blood flow and oxygen consumption during high-dose fentanyl anesthesia in patients with coronary artery disease. Anesthesiology 56:417\u2013422","journal-title":"Anesthesiology"},{"key":"2278_CR11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1152\/ajplegacy.1974.226.2.431","volume":"226","author":"DB Jennings","year":"1974","unstructured":"Jennings DB, Sparling J (1974) Effects of low O2 and high CO2 on cardiorespiratory function in conscious resting dogs. Am J Phys 226:431\u2013438","journal-title":"Am J Phys"},{"key":"2278_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-511X-7-42","volume":"7","author":"S Asgary","year":"2008","unstructured":"Asgary S, Sarrafzadegan N, Naderi GA, Rozbehani R (2008) Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter? Lipids Health Dis 7:42","journal-title":"Lipids Health Dis"},{"key":"2278_CR13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrcardio.2013.159","volume":"10","author":"F Masoudkabir","year":"2013","unstructured":"Masoudkabir F, Sarrafzadegan N, Eisenberg MJ (2013) Effects of opium consumption on cardiometabolic diseases. Nat Rev Cardiol 10:733\u2013740","journal-title":"Nat Rev Cardiol"},{"key":"2278_CR14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/pds.2131","volume":"20","author":"WJ Carman","year":"2011","unstructured":"Carman WJ, Su S, Cook SF, Wurzelmann JI, McAfee A (2011) Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort. Pharmacoepidemiol Drug Saf 20:754\u2013762","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2278_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/joim.12035","volume":"273","author":"L Li","year":"2013","unstructured":"Li L, Setoguchi S, Cabral H, Jick S (2013) Opioid use for noncancer pain and risk of myocardial infarction amongst adults. J Intern Med 273:511\u2013526","journal-title":"J Intern Med"},{"key":"2278_CR16","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","volume":"315","author":"WA Ray","year":"2016","unstructured":"Ray WA, Chung CP, Murray KT, Hall K, Stein CM (2016) Prescription of long-acting opioids and mortality in patients with chronic noncancer pain. JAMA 315:2415\u20132423","journal-title":"JAMA"},{"key":"2278_CR17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thorax.57.11.939","volume":"57","author":"AL Jennings","year":"2002","unstructured":"Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE (2002) A systematic review of the use of opioids in the management of dyspnoea. Thorax 57:939\u2013944","journal-title":"Thorax"},{"key":"2278_CR18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.327.7414.523","volume":"327","author":"AP Abernethy","year":"2003","unstructured":"Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C (2003) Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 327:523\u2013528","journal-title":"BMJ"},{"key":"2278_CR19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jpainsymman.2010.11.021","volume":"42","author":"DC Currow","year":"2011","unstructured":"Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P et al (2011) Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manag 42:388\u2013399","journal-title":"J Pain Symptom Manag"},{"key":"2278_CR20","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.9778\/cmajo.20120031","volume":"1","author":"GM Rocker","year":"2013","unstructured":"Rocker GM, Simpson AC, Young J, Horton R, Sinuff T, Demmons J et al (2013) Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients\u2019 experiences and outcomes. CMAJ Open 1:E27\u2013E36","journal-title":"CMAJ Open"},{"key":"2278_CR21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15412550903140865","volume":"6","author":"AS Gershon","year":"2009","unstructured":"Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T (2009) Identifying individuals with physician diagnosed COPD in health administrative databases. J COPD 6:388\u2013394","journal-title":"J COPD"},{"key":"2278_CR22","first-page":"67","volume":"10","author":"R Levy","year":"2003","unstructured":"Levy R, O\u2019Brien BJ, Sellors C, Grootendorst P, Willison D (2003) Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 10:67\u201371","journal-title":"Can J Clin Pharmacol"},{"key":"2278_CR23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/archinternmed.2010.17","volume":"170","author":"AS Gershon","year":"2010","unstructured":"Gershon AS, Wang C, Wilton AS, Raut R, To T (2010) Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med 170:560\u2013565","journal-title":"Arch Intern Med"},{"key":"2278_CR24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1183\/09031936.00008014","volume":"44","author":"NT Vozoris","year":"2014","unstructured":"Vozoris NT, Fischer HD, Wang X, Stephenson AL, Gershon AS, Gruneir A et al (2014) Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 44:332\u2013340","journal-title":"Eur Respir J"},{"key":"2278_CR25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1183\/13993003.01967-2015","volume":"48","author":"NT Vozoris","year":"2016","unstructured":"Vozoris NT, Wang X, Fischer HD, Bell CM, O\u2019Donnell DE, Austin PC et al (2016) Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 48:683\u2013693","journal-title":"Eur Respir J"},{"key":"2278_CR26","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1016\/S0828-282X(10)70412-8","volume":"26","author":"K Tu","year":"2010","unstructured":"Tu K, Mitiku T, Lee DS, Guo H, Tu JV (2010) Validation of physician billing and hospitalization data to identify patients with ischemic heart disease using data from the Electronic Medical Record Administrative data Linked Database (EMRALD). Can J Cardiol 26:e225\u2013e228","journal-title":"Can J Cardiol"},{"key":"2278_CR27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.24095\/hpcdp.33.3.06","volume":"33","author":"SE Schultz","year":"2013","unstructured":"Schultz SE, Rothwell DM, Chen Z, Tu K (2013) Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records. Chronic Dis Inj Can 33:160\u2013166","journal-title":"Chronic Dis Inj Can"},{"key":"2278_CR28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46:399\u2013424","journal-title":"Multivar Behav Res"},{"key":"2278_CR29","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA (2015) Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34:3661\u20133679","journal-title":"Stat Med"},{"key":"2278_CR30","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1001\/archinte.163.17.2006","volume":"163","author":"RS Eidelman","year":"2003","unstructured":"Eidelman RS, Hebert PR, Weisman SM, Hennekens CH (2003) An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 163:2006\u20132010","journal-title":"Arch Intern Med"},{"key":"2278_CR31","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","volume":"57","author":"GC Donaldson","year":"2002","unstructured":"Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57:847\u2013852","journal-title":"Thorax"},{"key":"2278_CR32","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1183\/09031936.04.00121404","volume":"23","author":"S Spencer","year":"2004","unstructured":"Spencer S, Calverley PM, Burge PS, Jones PW (2004) Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 23:698\u2013702","journal-title":"Eur Respir J"},{"key":"2278_CR33","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst JR, Vestbo J, Anzueto A, Locantore N, M\u00fcllerova H, Tal-Singer R, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators et al (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363:1128\u20131138","journal-title":"N Engl J Med"},{"key":"2278_CR34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1164\/ajrccm.154.4.8887592","volume":"154","author":"AF Connors Jr","year":"1996","unstructured":"Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ et al (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154:959\u2013967","journal-title":"Am J Respir Crit Care Med"},{"key":"2278_CR35","first-page":"1A","volume":"15S","author":"DE O\u2019Donnell","year":"2008","unstructured":"O\u2019Donnell DE, Hernandez P, Kaplan A, Aaron S, Bourbeau J, Marciniuk D et al (2008) Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease\u20142008 update\u2014highlights for primary care. Can Respir J 15S:1A\u20138A","journal-title":"Can Respir J"},{"key":"2278_CR36","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2016. http:\/\/goldcopd.org\/global-strategy-diagnosis-management-prevention-copd-2016 (Accessed October 2016)."},{"key":"2278_CR37","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.1995.03530210041028","volume":"274","author":"SW Wen","year":"1995","unstructured":"Wen SW, Hernandez R, Naylor CD (1995) Pitfalls in nonrandomized outcomes studies. The case of incidental appendectomy with open cholecystectomy. JAMA 274:1687\u20131691","journal-title":"JAMA"},{"key":"2278_CR38","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/sim.5705","volume":"32","author":"PC Austin","year":"2013","unstructured":"Austin PC (2013) The performance of different propensity-score methods for estimating marginal hazard ratios. Stat Med 32:2837\u20132849","journal-title":"Stat Med"},{"key":"2278_CR39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0025-6196(11)60749-0","volume":"84","author":"CE Argoff","year":"2009","unstructured":"Argoff CE, Silvershein DI (2009) A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs. Mayo Clin Proc 84:602\u2013612","journal-title":"Mayo Clin Proc"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-017-2278-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2278-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2278-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:55Z","timestamp":1659139255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-017-2278-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,29]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["2278"],"URL":"https:\/\/doi.org\/10.1007\/s00228-017-2278-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,29]]}}}